PCR can detect chromosomal translocations, such as the BCR-ABL1 fusion associated with certain leukemias, by amplifying specific DNA sequences. While conventional PCR can be used, RT-PCR is often preferred because it first converts RNA into complementary DNA (cDNA) using reverse transcriptase before amplification. The BCR-ABL1 fusion occurs when the BCR and ABL1 genes, normally located on different chromosomes, are joined due to a translocation. In PCR, specific primers targeting the BCR and ABL1 regions will not yield a product unless the fusion has occurred, allowing for sensitive detection of the BCR-ABL1 gene. Although DNA is generally more stable than RNA, RT-qPCR is commonly used for diagnosis as it can effectively identify the BCR-ABL1 mRNA. This method utilizes a forward primer for the BCR gene and a reverse primer for the ABL1 gene to confirm the presence of the fusion.